Ariadne,  4C-D,   α-Et-2C-D,   BL-3912 or Dimoxamine is a lesser-known psychedelic drug.   It is a homologue of 2C-D and DOM.   Ariadne was first synthesized by Alexander Shulgin.   In his book PiHKAL (Phenethylamines i Have Known And Loved),   Shulgin reported testing Ariadne up to a dose of 32 mg,   and reported that it produces psychedelia at a bare threshold.]  Very little data exists about the pharmacological properties,   metabolism,   and toxicity of Ariadne in humans apart from Shulgin’s limited testing.

However,  in more recent animal studies,   4C-D was shown to produce stimulus generalization in rats trained to respond to the drug MDMA.   This suggests that while 4C-D may lack hallucinogenic effects,   it might potentially produce empathogenic effects similar to those of MDMA if used at higher dose ranges,   beyond those trialed by Shulgin   (the potency of 4C-D in this study was similar to that of MDMA,   1.5 mg/kg,   which would equate to a dose of ~100 mg in a human).